ArticleMedComm2026

Integrated Genomic, Transcriptomic, and Circulating Biomarkers Predict Benefit to Immune Checkpoint Inhibitor Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer.

Lailing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.